The online version of this article (doi:10.1186/1477-7819-10-201) contains supplementary material, which is available to authorized users.
The authors declare that they have no competing interests.
DY, YT, NS, and KK performed chemotherapy as a team. TI and CY treated the patient using hyperthermia. DY drafted the manuscript. MY carried the data acquisition. All authors read and approved the final manuscript.
Hyperthermia has long been used in combination with chemotherapy or radiation therapy for the treatment of superficial malignancies, in part due to its sensitizing capabilities. Patients who suffer from superficial recurrences of breast cancer have poor clinical outcomes. Skin metastases may particularly impair the quality of life due to the physical appearance, odor and bleeding.
A 66-year-old woman underwent mastectomy and axillary lymph node dissection for breast cancer. Nine years post-operatively, local metastases developed in the left axillary area (measuring 5 cm in diameter). Initially the tumor did not respond to radiation therapy and chemotherapy. Therefore, we added hyperthermia combined with them. Eight weeks later, the tumor became nearly flat and the patient noted improved activity in her daily life.
Hyperthermia may accelerate the antitumor effects of radiation therapy and chemotherapy. This treatment provides an alternative for unresectable breast cancer skin metastases.
Uto Y, Hori H, Kubo K, Ichihashi M, Sakamoto N, Mette M, Inui T: GcMAF: our next generation immunotherapy. Nature. 2012, 485: S67-S70.
Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WLJ, van Rhoon GC, van Dijk JDP, Gonzalez Gonzalez D: Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials. Int J Radiat Oncol Biol Phys. 1996, 35: 731-744. 10.1016/0360-3016(96)00154-X. CrossRefPubMed
Lee HK, Antell AG, Perez CA, Straube WL, Ramachandran G, Myerson RJ, Emami B, Molmenti EP, Buckner A, Lockett MA: Superficial hyperthermia and irradiation for recurrent breast carcinoma of the chest wall: Prognostic factors in 196 tumors. Int J Radiat Oncol Biol Phys. 1998, 40: 365-375. 10.1016/S0360-3016(97)00740-2. CrossRefPubMed
Barnes JA, Dix DJ, Collins BW, Luft C, Allen JW: Expression of inducible Hsp70 enhances the proliferation of MCF-7 breast cancer cells and protects against the cytotoxic effects of hyperthermia. Cell Stress Chaperones. 2001, 6: 316-325. 10.1379/1466-1268(2001)006<0316:EOIHET>2.0.CO;2. PubMedCentralCrossRefPubMed
Kong G, Braun RD, Dewhirst MW: Hyperthermia enables tumor-specific nanoparticle delivery. Effect of particle size. Cancer Res. 2000, 60: 4440-4445. PubMed
Matteucci ML, Anyarambhatla G, Rosner G, Azuma C, Fisher PE, Dewhirst MW, Needham D, Thrall DE: Hyperthermia increases accumulation of technetium-99 m-labeled liposomes in feline sarcomas. Clin Cancer Res. 2000, 6: 3748-3755. PubMed
Griffin RJ, Okajima K, Barrios B, Song CW: Mild temperature hyperthermia combined with carbogen breathing increases tumor partial pressure of oxygen (pO2) and radio-sensitivity. Cancer Res. 1996, 56: 5590-5593. PubMed
Vujaskovic Z, Poulson JM, Gaskin AA, Thrall DE, Page RL, Charles HC, MacFall JR, Brizel DM, Meyer RE, Prescott DM: Temperature-dependent changes in physiologic parameters of spontaneous canine soft tissue sarcomas after combined radiotherapy and hyperthermia treatment. Int J Radiat Oncol Biol Phys. 2000, 46: 179-185. 10.1016/S0360-3016(99)00362-4. CrossRefPubMed
Vujaskovic Z, Kim DW, Jones E, Lan L, McCall L, Dewhirst MW, Craciunescu O, Stauffer P, Liotcheva V, Betof A, Blackwell K: A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer. Int J Hyperthermia. 2010, 26: 514-521. 10.3109/02656731003639364. PubMedCentralCrossRefPubMed
Craciunescu OI, Thrall DE, Vujaskovic Z, Dewhirst MW: Magnetic resonance imaging: a potential tool in assessing the addition of hyperthermia to neoadjuvant therapy in patients with locally advanced breast cancer. Int J Hyperthermia. 2010, 26: 625-637. 10.3109/02656736.2010.499526. PubMedCentralCrossRefPubMed
Iwase S, Yamamoto D, Kuroda Y, Kawaguchi T, Kitamura K, Odagiri H, Teramoto S, Akazawa K, Nagumo Y: Phase II trial of preoperative chemotherapy for breast cancer: Japan Breast Cancer Research Network (JBCRN)-02 trial. Anticancer Res. 2011, 31: 1483-1487. PubMed
Yamamoto D, Iwase S, Yoshida H, Kuroda Y, Yamamoto C, Kitamura K, Odagiri H, Nagumo Y: Efficacy of meloxicam in combination with preoperative chemotherapy for breast cancer - Japan Breast Cancer Research Network (JBCRN) 02–1 trial. Anticancer Res. 2011, 31: 3567-3571. PubMed
- The utility of hyperthermia for local recurrence of breast cancer
- BioMed Central
Neu im Fachgebiet Chirurgie
Mail Icon II